8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine has been researched along with Angiogenesis, Pathologic in 1 studies
8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine: adenosine receptor antagonist
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mino, RP | 1 |
Spoerri, PE | 1 |
Caballero, S | 1 |
Player, D | 1 |
Belardinelli, L | 1 |
Biaggioni, I | 1 |
Grant, MB | 1 |
1 other study available for 8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine and Angiogenesis, Pathologic
Article | Year |
---|---|
Adenosine receptor antagonists and retinal neovascularization in vivo.
Topics: Angiography; Animals; Animals, Newborn; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Pu | 2001 |